LexDanaLexDanabeta
Inventor

JINGYI XIANG

Inventor
US

Overview

4→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,479,924Constructs specifically recognizing Glypican 3 and uses thereof202511,447,564Constructs specifically recognizing glypican 3 and uses thereof202211,440,952Compositions for preventing or treating viral and other microbial infections202211,155,615Anti-ROR1 antibodies2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to EUREKA THERAPEUTICS INC (3)· patent assignee history
2021Patents assigned to FIVE PRIME THERAPEUTICS INC (1)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to INVISISHIELD TECH LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EUREKA THERAPEUTICS INC32021–2025
FIVE PRIME THERAPEUTICS INC12021
INVISISHIELD TECH LTD12022
Locations
LocationPatentsSpan
US42021–2025